|
|
Active Org.- |
Originator Org.- |
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.CN |
First Approval Date01 Jan 1999 |
比较双氯芬酸二乙胺2.32%凝胶和1.16%凝胶治疗急性踝关节扭伤患者的疗效和安全性的随机、双盲、多中心非劣效性研究
[Translation] A randomized, double-blind, multicenter, non-inferiority study comparing the efficacy and safety of diclofenac diethylamide 2.32% gel and 1.16% gel in the treatment of patients with acute ankle sprains
本研究的主要目的是证明双氯芬酸二乙胺(DDEA) 2.32% 相对于 DDEA 1.16% 在缓解急性踝关节扭伤疼痛方面的非劣效性
[Translation] The primary objective of this study was to demonstrate the non-inferiority of diclofenac diethylamide (DDEA) 2.32% compared to DDEA 1.16% in relieving pain in acute ankle sprains.
/ CompletedNot Applicable 3 种4mg 尼古丁咀嚼胶(2种受试制剂,一种参比制剂)的单剂量、开放性、三相交叉生物等效性研究
[Translation] A single-dose, open-label, three-phase crossover bioequivalence study of three 4 mg nicotine chewing gums (two test formulations and one reference formulation)
为了在中国注册Nicotinell咀嚼胶,将考察Nicotinell咀嚼胶4mg薄荷味和Nicotinell咀嚼胶4mg水果味中尼古丁的生物利用度(BA),评估中国健康成年男性吸烟者中单次经口给药后尼古丁的系统吸收率和吸收程度是否与一种力克雷咀嚼胶参比制剂等效。 除此之外,还将评估并总结安全性特征。
[Translation] To register Nicotinell chewing gum in China, the bioavailability (BA) of nicotine in Nicotinell chewing gum 4mg mint flavor and Nicotinell chewing gum 4mg fruit flavor will be investigated, and the systemic absorption rate and extent of nicotine after a single oral administration in healthy Chinese adult male smokers will be evaluated to be equivalent to a Nicorette chewing gum reference formulation. In addition, the safety profile will be evaluated and summarized.
/ CompletedNot Applicable 3 种2mg 尼古丁咀嚼胶(2种受试制剂,一种参比制剂)的单剂量、开放性、三相交叉生物等效性研究
[Translation] A single-dose, open-label, three-phase crossover bioequivalence study of three 2 mg nicotine chewing gums (two test formulations and one reference formulation)
为了在中国注册Nicotinell咀嚼胶,将考察Nicotinell咀嚼胶2mg薄荷味和Nicotinell咀嚼胶2mg水果味中尼古丁的生物利用度(BA),评估中国健康成年男性吸烟者中单次经口给药后尼古丁的系统吸收率和吸收程度是否与一种力克雷咀嚼胶参比制剂等效。 除此之外,还将评估并总结安全性特征。
[Translation] To register Nicotinell chewing gum in China, the bioavailability (BA) of nicotine in Nicotinell chewing gum 2mg mint flavor and Nicotinell chewing gum 2mg fruit flavor will be investigated, and the systemic absorption rate and extent of nicotine after a single oral administration in healthy Chinese adult male smokers will be evaluated to be equivalent to a Nicorette chewing gum reference formulation. In addition, the safety profile will be evaluated and summarized.
100 Clinical Results associated with NOVARTIS CONSUMER HEALTH SCHWEIZ AG
0 Patents (Medical) associated with NOVARTIS CONSUMER HEALTH SCHWEIZ AG
100 Deals associated with NOVARTIS CONSUMER HEALTH SCHWEIZ AG
100 Translational Medicine associated with NOVARTIS CONSUMER HEALTH SCHWEIZ AG